Chemo-Pharma Laboratories Ltd.

72.00 -1.00 ▼-1.4%

28 February 2024, 04:01:00 PM
Volume: 63

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.thechemopharmalaboratoriesltd.com
Market Cap 10.80 Cr.
Enterprise Value(EV) 4.81 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 8.97 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 8.03 Trailing Twelve Months Ending 2023-12
Industry PE 41.39 Trailing Twelve Months Ending 2023-12
Book Value / Share 87.30 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.82 Calculated using Price: 72.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.15 Cr. 1,500,000 Shares
FaceValue 10
About Chemo-Pharma Laboratories Ltd.
Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues.

Chemo-Pharma Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Chemo-Pharma Laboratories Ltd. Performance

1 Day
-1.37%
1 Week
-1.38%
1 Month
-5.88%
3 Month
+67.83%
6 Month
+105.13%
1 Year
+84.62%
2 Year
+72.46%
5 Year
+373.68%
10 Year
+233.33%

Chemo-Pharma Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 5.61 4.15 60.99 1 2.02 3.94 2.3 4.97 0.41
Return on Capital Employed (%) 7.52 5.96 68.41 7.54 2.5 4.69 2.86 3.24 0.74
Return on Assets (%) 5.2 3.9 57.64 0.96 2 3.88 2.27 4.99 0.42

Chemo-Pharma Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5 5 10 10 10 11 11 12 12 12
Non Curr. Liab. 0 0 0 0 0 0
Curr. Liab. 0 0 1 0 0 0 0 0 0 0
Minority Int.
Equity & Liab. 6 6 11 10 10 11 11 11 11 12
Non Curr. Assets 3 3 2 2 2 2 0 5 5 6
Curr. Assets 2 2 9 9 9 9 11 6 6 6
Misc. Exp. not W/O
Total Assets 6 6 11 10 10 11 11 11 11 12

Chemo-Pharma Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales
Other Income 1 0 6 1 1 1 1 1 1 1
Total Income 1 0 6 1 1 1 1 1 1 1
Total Expenditure 0 0 0 0 -1 0 0 -1 -1 0
PBIDT 0 0 5 1 0 1 0 0 0 1
Interest 0
Depreciation 0 0 0 0 0
Taxation 0 0 -1 -1 0 0 0 0 0 0
Exceptional Items
PAT 0 0 5 0 0 0 0 1 0 1
Adjusted EPS 2 1 31 1 1 3 2 4 0 9

Chemo-Pharma Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 6 -2 -5 5 0 0 -1
Cash Fr. Inv. 0 0 0 1 1 1 1 0 1 1
Cash Fr. Finan. -1 1 2 -2 0
Net Change 0 0 0 6 1 -5 6 1 -1 0
Cash & Cash Eqvt 0 0 0 7 8 3 9 2 1 1

Chemo-Pharma Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 27.89 27.89 27.89 27.89 27.89 27.89 27.89 27.89 27.89
Public 72.11 72.11 72.11 72.11 72.11 72.11 72.11 72.11 72.11
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Chemo-Pharma Laboratories Ltd. Announcements

Tue, 30 Jan 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Advertisement of Unaudited Financial Results for the Quarter and Nine Months Ended December 31 2023.
Mon, 29 Jan 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday January 29 2024
1. Approval the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31 2023 along with the Limited Review Report thereon. 2. Approved the Appointment of M/s Kavita Khatri & Associates Company Secretary as the Secretarial Auditor of the Company for the Financial Year 2023-24.
Mon, 29 Jan 2024
Appointment Of M/S Kavita Khatri & Associates Company Secretary As The Secretarial Auditor Of The Company For The Financial Year 2023-24
Appointment of M/s Kavita Khatri & Associates Company Secretary as the Secretarial Auditor of the Company for the Financial Year 2023-24

Chemo-Pharma Laboratories Ltd. Technical Scans

Wed, 28 Feb 2024
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Chemo-Pharma Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 377,475.37 1,570.50 -0.7%
Cipla Ltd. 119,187.32 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. 107,206.64 6,420.70 -0.4%
Zydus Lifesciences Ltd. 94,418.40 931.25 -1.2%
Divi's Laboratories Ltd. 93,236.55 3,512.15 -0.7%
Apollo Hospitals Enterprise Ltd. 91,390.97 6,371.85 -3.7%
Torrent Pharmaceuticals Ltd. 88,302.11 2,598.00 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.38 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 32.14 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.51 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.75 931.25 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-12 67.42 3,512.15 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.78 6,371.85 -3.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,598.00 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.05 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 4.60 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.86 931.25 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-12 7.15 3,512.15 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.53 6,371.85 -3.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,598.00 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 931.25 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,512.15 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,371.85 -3.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 931.25 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,512.15 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,371.85 -3.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,598.00 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 931.25 -1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,512.15 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,371.85 -3.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,598.00 -1.0%

Chemo-Pharma Laboratories Ltd. FAQ's

What is Chemo Pharma Labs share price?

Can I buy Chemo Pharma Labs shares now?

What is the Market Cap of Chemo Pharma Labs?

What are the key metrics to analyse Chemo Pharma Labs?

What is the 52 Week High and Low of Chemo Pharma Labs?

What is the trend of Chemo Pharma Labs share price?